Monday, March 19, 2018​

   
8:00 a.m.

Breakfast and Registration 

8:30 a.m.

Welcome Address: Dean Bernard Ferrari

8:45 a.m.

Current Legislative, Market, & Regulatory Approaches to Drug Accessibility

Speakers:

  • Gerard Anderson, PhD, Johns Hopkins Bloomberg School of Public Health
  • William Padula, PhD, Johns Hopkins Bloomberg School of Public Health
  • Byron Wornson, Vice President Global Health and Value, Pfizer

Moderator: Sarah Karlin-Smith, POLITICO 

10:20 a.m.

Pricing Interventions and Business Interventions to Solve the Accessibility Problem

Speakers:

  • Joanna Shepherd, PhD, Emory University School of Law
  • Ge Bai, PhD, CPA, Johns Hopkins Carey Business School
  • Sharon Glave Frazee, PhD, MPH, Pharmacy Benefit Management Institute
  • David Yakimischak, MBA, ConnectiveRx

Moderator: Ozge Sahin, PhD, Johns Hopkins Carey Business School 

11:45 a.m.

Luncheon and Keynote Address

Keynote Address by Dan Liljenquist, Intermountain Healthcare

Fireside Chat with Gerard Anderson, PhD, Johns Hopkins Bloomberg School of Public Health 

1:40 p.m.

Biologics, Biopharma Research, The Drug Pipeline and Ethical Considerations for Consumer Access

Speakers:

  • Jennifer E. Miller, PhD, NYU School of Medicine
  • Christopher Robertson, JD, PhD, University of Arizona
  • James E. Rogers College of Law
  • Jeremy Greene, MD, PhD, MA, Johns Hopkins Bloomberg School of Public Health
  • Alison Bateman-House, MPH, PhD, NYU School of Medicine

Moderator: Ge Bai, PhD, CPA, Johns Hopkins Carey Business School

3:10 p.m.

"Where Do We Go From Here?": Summary of Key Lessons and Business Responses Going Forward

Speakers:

  • Jay Bhattacharya, MD, PhD, Stanford Medical School & Stanford Institute for Economic Policy Research
  • Caleb Alexander, MD, Johns Hopkins Medical Center
  • Rujul Desai, JD, Avalere Health 

Moderator: David Yakimischak, MBA, ConnectiveRx 

4:30 p.m.  Networking Reception